Previously, Gao et al., performed a CRISPR/Cas9 screen in the presence of a PRMT5 inhibitor using a small library targeting epigenetic regulators (1016 in total) in non-small cell lung cancer cells. This evidence concerns the gene PRMT5 and non-small cell lung carcinoma.